Literature DB >> 8794004

Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transduction.

M F Lavin1, Y Shiloh.   

Abstract

The gene responsible for the defect in the human genetic disorder ataxia-telangiectasia, ATM, was cloned recently. The part of the gene coding for a phosphatidylinositol 3-kinase domain showed it to be related to a family of genes involved in signal transduction, cell cycle control and the response to DNA damage. The elucidation of the role of the ATM gene product will provide valuable insight into the radiosensitivity, cancer predisposition, immunodeficiency and neuropathology that characterize this syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794004     DOI: 10.1016/s0952-7915(96)80030-6

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  13 in total

1.  Spontaneous and oxidative stress-induced programmed cell death in lymphocytes from patients with ataxia telangiectasia (AT).

Authors:  R Schubert; J Reichenbach; N Royer; M Pichler; S Zielen
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

2.  Induction and characterization of human glioma clones with different radiosensitivities.

Authors:  J Wang; L Hu; N Gupta; T Shamseldin; T Ozawa; J Klem; M Cardell; D F Deen
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

3.  Mitochondrial dysfunction in ataxia-telangiectasia.

Authors:  Yasmine A Valentin-Vega; Kirsteen H Maclean; Jacqueline Tait-Mulder; Sandra Milasta; Meredith Steeves; Frank C Dorsey; John L Cleveland; Douglas R Green; Michael B Kastan
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

4.  Novel mutations and defective protein kinase C activation of T-lymphocytes in ataxia telangiectasia.

Authors:  M A García-Pérez; L M Allende; A Corell; P Varela; A A Moreno; A Sotoca; A Moreno; E Paz-Artal; E Barreiro; A Arnaiz-Villena
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

5.  ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

Authors:  A Broeks; J H Urbanus; A N Floore; E C Dahler; J G Klijn; E J Rutgers; P Devilee; N S Russell; F E van Leeuwen; L J van 't Veer
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

6.  Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.

Authors:  L Qiu; A Burgess; D P Fairlie; H Leonard; P G Parsons; B G Gabrielli
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

7.  2-Deoxy-D-glucose and ferulic acid modulates radiation response signaling in non-small cell lung cancer cells.

Authors:  Venkata Reddy Bandugula; Rajendra Prasad N
Journal:  Tumour Biol       Date:  2012-10-12

8.  Deficiencies in CD4+ and CD8+ T cell subsets in ataxia telangiectasia.

Authors:  R Schubert; J Reichenbach; S Zielen
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

9.  KARP-1 is induced by DNA damage in a p53- and ataxia telangiectasia mutated-dependent fashion.

Authors:  K Myung; C Braastad; D M He; E A Hendrickson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

10.  Critical DNA damaging pathways in tumorigenesis.

Authors:  Jake A Kloeber; Zhenkun Lou
Journal:  Semin Cancer Biol       Date:  2021-04-24       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.